Literature DB >> 11204270

Cell lineage analysis during liver development using the spf(ash)-heterozygous mouse.

N Shiojiri1, S Inujima, K Ishikawa, K Terada, M Mori.   

Abstract

Biliary epithelial cells differentiate from periportal hepatoblasts during fetal mouse liver development. It remains to be determined whether each hepatoblast is equivalent for differentiation into hepatocytes and biliary epithelial cells in normal liver development. To resolve this question, the mosaic pattern of ornithine transcarbamylase (OTC) expression was analyzed in the hepatoblast population of spf(ash) (sparse-fur with abnormal skin and hair)-heterozygous fetal mouse livers, in which random inactivation of either the X chromosome carrying the spf(ash) gene (causing OTC deficiency) or its wild-type gene occurs. Aggregates (patches) of OTC-positive hepatoblasts showed very complex patterns, and their shapes and size distributions were similar in sections from periportal regions and nonperiportal regions of the fetal liver in which bile duct differentiation by periportal hepatoblasts occurred. Average sizes of periportal patches were larger than those of nonperiportal patches because of the presence of more hemopoietic cells in the latter region. The OTC mosaicism in periportal bile duct progenitors and hepatoblast islands of other liver parenchyma was also similar. These results suggest that the growth patterns of hepatoblasts are similar in both periportal and nonperiportal regions. Isolated three-dimensional patches comprising hepatoblasts giving rise to only biliary epithelial cells or hepatoblasts giving rise to both hepatocytes and biliary epithelial cells were observed in periportal regions. In nonperiportal regions, patches consisting of hepatoblasts differentiating into hepatocytes were also seen. Thus, it is likely that there are three lineages for the developmental fates of hepatoblasts: hepatoblasts giving rise to only biliary epithelial cells, hepatoblasts giving rise to only hepatocytes, and hepatoblasts giving rise to both of them.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11204270     DOI: 10.1038/labinvest.3780208

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  7 in total

1.  Single-cell murine genetic fate mapping reveals bipotential hepatoblasts and novel multi-organ endoderm progenitors.

Authors:  Gabriel K El Sebae; Joseph M Malatos; Mary-Kate E Cone; Siyeon Rhee; Jesse R Angelo; Jesse Mager; Kimberly D Tremblay
Journal:  Development       Date:  2018-10-11       Impact factor: 6.868

2.  Mosaic analysis of small intestinal development using the spf(ash)-heterozygous female mouse.

Authors:  Nobuyoshi Shiojiri; Masataka Mori
Journal:  Histochem Cell Biol       Date:  2003-02-13       Impact factor: 4.304

Review 3.  Stem cells in liver regeneration and their potential clinical applications.

Authors:  Ioannis Drosos; George Kolios
Journal:  Stem Cell Rev Rep       Date:  2013-10       Impact factor: 5.739

4.  Hepatoblast and mesenchymal cell-specific gene-expression in fetal rat liver and in cultured fetal rat liver cells.

Authors:  Tümen Mansuroglu; József Dudás; Abderrahim Elmaouhoub; Tobias Z Joza; Giuliano Ramadori
Journal:  Histochem Cell Biol       Date:  2009-04-19       Impact factor: 4.304

5.  Foxl1 is a marker of bipotential hepatic progenitor cells in mice.

Authors:  Sara D Sackett; Zhaodong Li; Reginald Hurtt; Yan Gao; Rebecca G Wells; Karrie Brondell; Klaus H Kaestner; Linda E Greenbaum
Journal:  Hepatology       Date:  2009-03       Impact factor: 17.425

6.  Lgr5+ stem and progenitor cells reside at the apex of a heterogeneous embryonic hepatoblast pool.

Authors:  Nicole Prior; Christopher J Hindley; Fabian Rost; Elena Meléndez; Winnie W Y Lau; Berthold Göttgens; Steffen Rulands; Benjamin D Simons; Meritxell Huch
Journal:  Development       Date:  2019-06-12       Impact factor: 6.868

7.  A transmembrane glycoprotein, gp38, is a novel marker for immature hepatic progenitor cells in fetal mouse livers.

Authors:  Sayuri Konishi; Kentaro Yasuchika; Takamichi Ishii; Ken Fukumitsu; Naoko Kamo; Naoya Fujita; Iwao Ikai; Shinji Uemoto
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-11-20       Impact factor: 2.416

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.